Stability of proton pump inhibitors for use in hypersensitivity evaluation. [PDF]
Wanandy T +6 more
europepmc +1 more source
Proton pump inhibitor exposure modulates functional and transcriptional responses in <i>Lactobacillus acidophilus</i>: a comprehensive computational and experimental insights. [PDF]
Naorem RS, Dutta K, Bora SS, Teli AB.
europepmc +1 more source
Reply: Including Vonoprazan With PPIs Challenges the Drug-Interaction Hypothesis. [PDF]
Nishikura T +4 more
europepmc +1 more source
Potassium-Competitive Acid Blockers for First-Line <i>Helicobacter pylori</i> Eradication: A Systematic Review and Meta-Analysis. [PDF]
Kovarbasic CA +4 more
europepmc +1 more source
Evaluation of Rabeprazole for Gastrointestinal Protection in Acute Coronary Syndrome Patients Treated with Aspirin and Ticagrelor: A Pilot Study. [PDF]
Hyun HK +5 more
europepmc +1 more source
Vonoprazan versus rabeprazole in dual therapy with amoxicillin for Helicobacter pylori eradication: a prospective, multicenter, open-label, randomized controlled trial. [PDF]
Wang H +9 more
europepmc +1 more source
Impact of PAR2 on Tight Junctions and Esophageal Mucosal Inflammation in Rats with Gastroesophageal Reflux Disease. [PDF]
Du M +5 more
europepmc +1 more source
Response to: "Proton-pump inhibitor use in combination with a CDK4/6 inhibitor: is formulation the issue?" [PDF]
Chen BF, Huang CC.
europepmc +1 more source
Rifasutenizol-Based Triple Therapy for the Eradication of Helicobacter pylori. [PDF]
Kim YJ.
europepmc +1 more source
Real-world effectiveness of vonoprazan-based regimen versus rabeprazole-based dual therapy for <i>Helicobacter pylori</i> eradication in a high-resistance, multi-ethnic region: a multicenter study in Guizhou, China. [PDF]
Huang Y +12 more
europepmc +1 more source

